Record Information
Version1.0
Creation Date2009-06-02 22:18:41 UTC
Update Date2026-03-27 00:47:58 UTC
Accession NumberCHEM000715
Identification
Common Name2,4-Dichlorophenoxybutyric acid
ClassSmall Molecule
Description2,4-DB or 4-(2,4-dichlorophenoxy)butyric acid is a selective systemic phenoxy herbicide used to control many annual and perennial broadleaf weeds in alfalfa, peanuts, soybeans, and other crops. Its active metabolite, 2,4-D, inhibits growth at the tips of stems and roots. It is classified in toxicity class III.
Contaminant Sources
  • Clean Air Act Chemicals
  • HPV EPA Chemicals
  • IARC Carcinogens Group 2B
  • STOFF IDENT Compounds
  • T3DB toxins
  • ToxCast & Tox21 Chemicals
Contaminant Type
  • Aromatic Hydrocarbon
  • Ether
  • Organic Compound
  • Organochloride
  • Pesticide
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
2,4-D Butyric acidChEBI
4-(2,4-DB)ChEBI
4-(2,4-Dichlorophenoxy)butyric acidChEBI
ButoxoneChEBI
ButyracChEBI
EmbutoxChEBI
gamma-(2,4-Dichlorophenoxy)-butanoic acidChEBI
gamma-(2,4-Dichlorophenoxy)-butyric acidChEBI
gamma-(2,4-Dichlorophenoxy)butanoic acidChEBI
gamma-(2,4-Dichlorophenoxy)butyric acidChEBI
LegumexChEBI
2,4-D ButyrateGenerator
4-(2,4-Dichlorophenoxy)butyrateGenerator
g-(2,4-Dichlorophenoxy)-butanoateGenerator
g-(2,4-Dichlorophenoxy)-butanoic acidGenerator
gamma-(2,4-Dichlorophenoxy)-butanoateGenerator
Γ-(2,4-dichlorophenoxy)-butanoateGenerator
Γ-(2,4-dichlorophenoxy)-butanoic acidGenerator
g-(2,4-Dichlorophenoxy)-butyrateGenerator
g-(2,4-Dichlorophenoxy)-butyric acidGenerator
gamma-(2,4-Dichlorophenoxy)-butyrateGenerator
Γ-(2,4-dichlorophenoxy)-butyrateGenerator
Γ-(2,4-dichlorophenoxy)-butyric acidGenerator
g-(2,4-Dichlorophenoxy)butanoateGenerator
g-(2,4-Dichlorophenoxy)butanoic acidGenerator
gamma-(2,4-Dichlorophenoxy)butanoateGenerator
Γ-(2,4-dichlorophenoxy)butanoateGenerator
Γ-(2,4-dichlorophenoxy)butanoic acidGenerator
g-(2,4-Dichlorophenoxy)butyrateGenerator
g-(2,4-Dichlorophenoxy)butyric acidGenerator
gamma-(2,4-Dichlorophenoxy)butyrateGenerator
Γ-(2,4-dichlorophenoxy)butyrateGenerator
Γ-(2,4-dichlorophenoxy)butyric acidGenerator
2,4-DichlorophenoxybutyrateGenerator
2,4-DBMeSH
2,4 DMMeSH
2,4-DMMeSH
4-(2,4-Dichlorophenoxy)butyric acid, ammonium saltMeSH
4-(2,4-Dichlorophenoxy)butyric acid, manganese(2+) saltMeSH
4-(2,4-Dichlorophenoxy)butyric acid, sodium saltMeSH
4-(2,4-Dichlorophenoxy)butyric acid, copper(2+) saltMeSH
4-(2,4-Dichlorophenoxy)butyric acid, potassium saltMeSH
Chemical FormulaC10H10Cl2O3
Average Molecular Mass249.091 g/mol
Monoisotopic Mass248.001 g/mol
CAS Registry Number94-82-6
IUPAC Name4-(2,4-dichlorophenoxy)butanoic acid
Traditional Namebutyrac
SMILESOC(=O)CCCOC1=CC=C(Cl)C=C1Cl
InChI IdentifierInChI=1S/C10H10Cl2O3/c11-7-3-4-9(8(12)6-7)15-5-1-2-10(13)14/h3-4,6H,1-2,5H2,(H,13,14)
InChI KeyYIVXMZJTEQBPQO-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as dichlorobenzenes. Dichlorobenzenes are compounds containing a benzene with exactly two chlorine atoms attached to it.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassHalobenzenes
Direct ParentDichlorobenzenes
Alternative Parents
Substituents
  • Phenoxy compound
  • Phenol ether
  • 1,3-dichlorobenzene
  • Alkyl aryl ether
  • Aryl chloride
  • Aryl halide
  • Carboxylic acid derivative
  • Carboxylic acid
  • Ether
  • Monocarboxylic acid or derivatives
  • Organooxygen compound
  • Organic oxygen compound
  • Carbonyl group
  • Organic oxide
  • Hydrocarbon derivative
  • Organohalogen compound
  • Organochloride
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
Applications
Biological Roles
Chemical RolesNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point118°C
Boiling PointNot Available
Solubility0.046 mg/mL at 25°C [TOMLIN,C (1994)]
Predicted Properties
PropertyValueSource
Water Solubility0.11 g/LALOGPS
logP3.19ALOGPS
logP3.03ChemAxon
logS-3.3ALOGPS
pKa (Strongest Acidic)3.58ChemAxon
pKa (Strongest Basic)-4.9ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area46.53 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity57.67 m³·mol⁻¹ChemAxon
Polarizability23.48 ųChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-000t-1090000000-de21dab06a16d9dd594dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0f79-5980000000-d0e043f212807520d758Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-0006-9500000000-4b1c202a64296810a0bbSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-0002-0390000000-bd4c785c99731f0c92b6Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-03di-0950000000-b1a394053669af6dae72Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-03di-1900000000-728872f0231b0d0a25feSpectrum
MSMass Spectrum (Electron Ionization)splash10-03di-7900000000-5d6f201d2468101b3001Spectrum
1D NMR13C NMR SpectrumNot AvailableSpectrum
Toxicity Profile
Route of ExposureNot Available
Mechanism of ToxicitySome of the endocrine effects of 2,4-DB may be mediated by the 2,4-D mediated displacement of sex hormones from the sex hormone binding globulin or the 2,4-D mediated blocking or OAT6 transport proteins that are needed for the transport of functional organic ions and dicarboxylates (including estrone sulfate).
MetabolismCDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, distributing mainly to the liver and adipose tissue. CDDs are very slowly metabolized by the microsomal monooxygenase system to polar metabolites that can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing CDDs induce both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the feces, though smaller amounts are excreted in the urine and via lactation. (3)
Toxicity ValuesLD50: 370-700 mg/kg (Oral, Rat); LD50: 2000 mg/kg (Dermal, Rabbit) (6)
Lethal DoseNot Available
Carcinogenicity (IARC Classification)2B, possibly carcinogenic to humans. (2)
Uses/SourcesBroadleaf herbicide, widely used in agriculture, functions as a synthetic auxin. (3, 4)
Minimum Risk LevelNot Available
Health EffectsAll forms of 2,4-DB are considered low in toxicity when absorbed via skin or via inhalation. Female rats fed moderate doses of 75 mg/kg of 2,4-DB, experienced a number of chronic effects including lower ovarian weights, fewer offspring born and lower overall body weight. In addition, numerous offspring (pups) died during lactation.
SymptomsSymptoms of acute oral exposure include vomiting, diarrhea, headache, confusion, renal failure, aggressive or bizarre behavior, hypotension and muscle twitching. Skeletal muscle injury and renal failure may also occur. Prolonged dermal exposure may include skin irritation, whereas prolonged inhalation exposure may lead to coughing and burning sensations in the upper respiratory tract and chest. (3)
TreatmentThe general treatment of acute chlorophenoxy herbicide poisoning consists of decontamination of the gastrointestinal tract, resuscitation and supportive care. For severe, acute oral poisoning by 2,4-DB or 2,4-D, forced alkaline diuresis appears to be most effective (1). Forced alkaline diuresis is often used to increase the excretion of acidic drugs like salicylates and phenobarbitone. For forced alkaline diuresis, a diuretic like furosemide is given intravenously and sodium bicarbonate is added to the infusion fluid to make blood and, in turn, urine alkaline. Potassium replacement becomes of utmost importance during the process because potassium is usually lost in urine. If blood levels of potassium are depleted below normal levels, then hypokalemia occurs, which promotes bicarbonate ion retention and prevents bicarbonate excretion, thus interfering with the alkalinization of the urine.
Concentrations
Not Available
DrugBank IDNot Available
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia Link2,4-DB
Chemspider IDNot Available
ChEBI ID73173
PubChem Compound ID1489
Kegg Compound IDC14404
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available